Category :

Pharmaceuticals and Biotech Press Releases

ImmunoReagents and BIOZOL Announce Corporate Alliance

ImmunoReagents and BIOZOL Announce Corporate AllianceNews Release, Friday, August 18, 2017, 08:30 AM ESTRALEIGH, NC, USA – August 18, 2017 – Leading Life Science Reagent Manufacturer ImmunoReagents joins forces with BIOZOL, and announced the appointment of BIOZOL as its new…

Actuated Medical, Inc. Recognized Internationally, Nationally, And Regionally In 2017

Actuated Medical, Inc. has been recognized by international, national, and regional publications and organizations in 2017.AMI was recognized by the Corporate LiveWire Healthcare and Life Sciences Awards 2017 for Excellence in Medical Supply Services – PA, USA.  Nominations for the…

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced an update on business results including strong revenue growth of 25% to $10.3 million, substantial improvement…

Resourceful HR Recognized on the 2017 Inc. 5000 list

Resourceful HR Recognized on the 2017 Inc. 5000 list

Resourceful HR, LLC, announced today that Inc. recognized Resourceful HR on its 36th annual Inc. 5000 List, the most prestigious ranking of the nation's fastest-growing private companies. The list honors companies for their excellence in strategy, service, and innovation. The…

Cell Therapy Manufacturing Market Well Set to Meet Exponential Demand

Roots Analysis has announced the addition of "Cell Therapy Manufacturing Market, 2017-2027" report to its list of offerings. The report provides an extensive study on the current landscape of the rapidly growing market of cell therapy manufacturing and focuses both…

Vivreon Biosciences Achieves Milestones in SBIR Grant from the National Institute of Aging

Vivreon Biosciences, LLC has successfully achieved milestones laid out in the Phase I portion of it's Fast-Track Small Business Innovation Research (SBIR) grant originally awarded in September of 2016. The grant was awarded from the National Institute on Aging (NIA)…

New Generation Antibacterials to Witness Annualized Growth of Over 30%, reports Roots Analysis

Roots Analysis has announced the addition of "Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026" report to its portfolio. The report provides an extensive study of the market current landscape and the growing pipeline of new generation antibiotics…

Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas

Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas

Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical company, today announced that the Food and Drug Administration (FDA) has granted orphan drug designation to CT-179, the company's lead Olig2 inhibitor for the treatment of gliomas, including glioblastoma (GBM) in adults and…

ivWatch Achieves ISO 13485 Certification: Provides Foundation for International Distribution

ivWatch Achieves ISO 13485 Certification: Provides Foundation for International Distribution

ivWatch LLC, a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy, today announced receipt of its ISO 13485 Certification, the global standard for medical device quality management systems (QMS) developed by the International Organization…

Fusion Antibodies Ltd (UK) and Synbio Technologies Co. Ltd announced a partnership

Fusion Antibodies Ltd (UK) and Synbio Technologies Co. Ltd (China/USA) are excited to announce a commercial partnership to support biologic drug development in China.1st June 2017 – Fusion Antibodies Ltd (Belfast, UK) and Synbio Technologies Co Ltd (China/USA), today announce…

Tel Aviv University Announces Collaboration with Biosynth on Pioneering Chemiluminescent Molecules

Biosynth, a global company supplying intermediate chemicals to the life science industry and Tel Aviv University (TAU) through Ramot its Business Engagement Center, announce the signing of a licensing agreement giving Biosynth the right to manufacture and sell probes invented…

Jurox Enters Partnership With Dermatology Company Stratford Animal Health

​Jurox Animal Health USA has announced the completion of comprehensive sales and a co-marketing agreement with Stratford Pharmaceuticals, located in Oldsmar, FL. Stratford serves over 8,000 veterinary hospitals with premium dermatology, joint health, oral and otic products for companion animals. The agreement, according to Jim Van Proosdy, Jurox Animal Health’s COO and U.S business…

Eastern Europe's Andrew De Niese to Come to America to Learn More About Pharm.D.

Eastern Europe's Andrew De Niese to Come to America to Learn More About Pharm.D.

Andrew De Niese is from Ukraine and has devoted many hours over the past six years to pharmacy. But he has recently become friends with fellow Pharm.D. program students from California and has planned a trip to come to America…

Synbio Tech. Announced the Establishment of Cooperative Relations with ALSTEM

Synbio Technologies Announced the Establishment of Cooperative Relations with ALSTEMSynbio Technologies, a leading international synthetic biology service company, recently announced a new partnership with ALSTEM, LLC, a US biotech company, with the aim of developing various human CRISPR-Cas9 sgRNA libraries.…

Rhemutoid Arthrities:Beyond TNF Inhibitor

Roots Analysis has announced the addition of the "Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026" report to its list of offerings. The report provides a comprehensive analysis of the current market landscape of therapies for the treatment of rheumatoid arthritis, specifically,…

Vivreon Biosciences Announces Hiring of Chief Scientific Officer

Vivreon Biosciences, LLC announces the hiring of industry veteran John T. Ransom, Ph.D., as its new Chief Scientific Officer. Dr. Ransom will be in charge of leading Vivreon's drug development programs in ulcerative colitis, Alzheimer's disease, and Parkinson's disease, all…

Theragnostic Technologies Receives Phase 1 SBIR Grant from National Institutes of Health (NIH)

Theragnostic Technologies announced today that it has received an Small Business Innovation Research (SBIR) Phase 1 grant from National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK)/ National Institutes of Health (NIH). The funds will be used to demonstrate…

Mesa Biotech to Present at Next Generation Dx Summit in Washington, DC

Mesa Biotech, Inc., a privately-held, molecular diagnostic company that has developed a testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced that it will present at the ninth annual Next Generation Dx Summit to be held August…

Synbio Technologies to attend PEGS 2017

Visit our booth, # 112, to learn more about Synbio Technologies' advanced "GPS" (Genotype-Phenotype-Synotype) platforms and comprehensive biological solutions. Our scientific capabilities encompass areas such as: DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology…

Bioanalytical Systems to Release Third Quarter Fiscal 2017 Results on Monday, August 14, 2017

Bioanalytical Systems to Release Third Quarter Fiscal 2017 Results on Monday, August 14, 2017

Bioanalytical Systems, Inc. (NASDAQ:BASI) ("BASi" or the “Company") announced today that it will report financial results for the third quarter and nine months ended June 30, 2017, prior to the market opening on Monday, Aug. 14, 2017. If there are any…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login